The Subject Of The Contract Is The Supply Of Reagents For The Needs Of The 1St Intensive Care Clinic Of The School Of Medicine Of The Ekpa, In The Context Of The Project/Program Of The Special Research Funds Account With K.Ε 20444 And Title "Evaluation Of Mepolizumab Effectiveness In Patients With Chronic Rhinosinusitis With Nasal Polyps And Comorbid Severe Eosinophilic Asthma: An Integrative Multi-Omics Approach To Assess Biomarker Signatures Of Responsive Disease Endotypes'. The Supply Of Reagents Is Deemed Necessary And Serves The Analysis Of Patient Samples (Dna, Rna, Proteins). The Total Estimated Value Of The Contract Amounts To Seventy-Eight Thousand And Seventy-Seven Euros And Eighty-Two Cents (€78,077.82) Plus Vat. 6% And 24%, I.E. In The Amount Of Eighty-Two Thousand Nine Hundred And Twenty-Eight Euros And Ninety-Nine Cents (€82,928.99), Including Vat. (Departments 1, 2, 3 And 5 Are Subject To 6% Vat And Section 4 Is Subject To 24% Vat).